Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Hematology | Musculoskeletal | Family Medicine
Disease Category: Multiple Myeloma
Location: United States, WV
SNS01-T-001 - Phase 1/2 Open-Label, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of SNS01-T Administered by Intravenous Infusion in Patients with Relapsed or Refractory Multiple Myeloma
Patient Inclusion Criteria: See www.hsc.wvu.edu/mbrcc/ctru/ for additional information.
Patient Exclusion Criteria: See www.hsc.wvu.edu/mbrcc/ctru/ for additional information.
West Virginia University - Clinical Trials Research Unit
PO Box 9260
Morgantown, WV 26506
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these